These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 1314389)

  • 1. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.
    Weiner AJ; Geysen HM; Christopherson C; Hall JE; Mason TJ; Saracco G; Bonino F; Crawford K; Marion CD; Crawford KA
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3468-72. PubMed ID: 1314389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins.
    Weiner AJ; Brauer MJ; Rosenblatt J; Richman KH; Tung J; Crawford K; Bonino F; Saracco G; Choo QL; Houghton M
    Virology; 1991 Feb; 180(2):842-8. PubMed ID: 1846505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
    Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
    Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on peptide. XIX: Hepatitis C virus (HCV) immune selection].
    Liu G; Liang ZL; Cai MS; Sun T; Zhuang H; Tao QM; Guo JP
    Yao Xue Xue Bao; 1996; 31(5):358-63. PubMed ID: 9275714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates.
    Inchauspe G; Zebedee S; Lee DH; Sugitani M; Nasoff M; Prince AM
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10292-6. PubMed ID: 1658800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus.
    Kato N; Ootsuyama Y; Ohkoshi S; Nakazawa T; Sekiya H; Hijikata M; Shimotohno K
    Biochem Biophys Res Commun; 1992 Nov; 189(1):119-27. PubMed ID: 1333186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.
    Bassett SE; Thomas DL; Brasky KM; Lanford RE
    J Virol; 1999 Feb; 73(2):1118-26. PubMed ID: 9882313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants.
    Lesniewski RR; Boardway KM; Casey JM; Desai SM; Devare SG; Leung TK; Mushahwar IK
    J Med Virol; 1993 Jun; 40(2):150-6. PubMed ID: 7689636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.
    Ray R; Khanna A; Lagging LM; Meyer K; Choo QL; Ralston R; Houghton M; Becherer PR
    J Virol; 1994 Jul; 68(7):4420-6. PubMed ID: 8207814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus (HCV)-RNA in non-A, non-B chronic hepatitis in France. Nucleotide sequence of a French HCV isolate.
    Kremsdorf D; Porchon C; Brechot C
    J Hepatol; 1991; 13 Suppl 4():S24-32. PubMed ID: 1668329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain.
    Sherman KE; Andreatta C; O'Brien J; Gutierrez A; Harris R
    Hepatology; 1996 Apr; 23(4):688-94. PubMed ID: 8666318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
    Rosa D; Campagnoli S; Moretto C; Guenzi E; Cousens L; Chin M; Dong C; Weiner AJ; Lau JY; Choo QL; Chien D; Pileri P; Houghton M; Abrignani S
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1759-63. PubMed ID: 8700831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.
    Jackson P; Petrik J; Alexander GJ; Pearson G; Allain JP
    J Med Virol; 1997 Jan; 51(1):67-79. PubMed ID: 8986952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A correlation between the heterogeneity of hypervariable region 1 of E2 glycoprotein of Hepatitis C virus (HCV) and HCV antibody profile: a case study.
    Kmieciak D; Biernacka-Lukanty J; Migdalski P; Turek-Plewa J; Wierzbicki A; Juszczyk J; Trzeciak WH
    Acta Virol; 2005; 49(2):97-103. PubMed ID: 16047736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.
    Simmonds P; Rose KA; Graham S; Chan SW; McOmish F; Dow BC; Follett EA; Yap PL; Marsden H
    J Clin Microbiol; 1993 Jun; 31(6):1493-503. PubMed ID: 7686182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies.
    Lee JW; Kim Km; Jung SH; Lee KJ; Choi EC; Sung YC; Kang CY
    J Virol; 1999 Jan; 73(1):11-8. PubMed ID: 9847301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.